Clinical Trial Update: Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating antroquinonol for efficacy and safety/tolerability in adults with acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Antroquinonol (antroquinonol)

Snippet

Sponsor: Golden Biotechnology Corporation | Conditions: Leukemia, Myeloid, Acute | Phase 2 | Status: COMPLETED